Skip to main navigation Skip to search Skip to main content

Cardiac involvement with amyloidosis: mechanisms of disease, diagnosis and management

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

The amyloidoses represent a group of clinical disorders of diverse etiologies that have as a common pathophysiologic denominator the deposition of misfolded protein based amyloid fibrils in the interstitial space of various organs. They are uncommon diseases with protean clinical presentations. Cardiac involvement is the determining factor for a patient's prognosis. Clinicians have to maintain a high index of suspicion and actively search for signs and symptoms of cardiac involvement in patients with preexisting conditions known to be associated with the development of amyloidosis. Early diagnosis and accurate fibril typing are the first steps in managing the disease. Judicious use of various diagnostic modalities such as serum markers and imaging studies, and good communication among all the physicians involved in the care of these sick and frail patients, are keys to a better outcome.

Original languageEnglish
Pages (from-to)581-90
Number of pages10
JournalConnecticut medicine
Volume75
Issue number10
Publication statusPublished - 6 Jan 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Amyloidosis
  • Cardiomyopathies
  • Death, Sudden, Cardiac
  • Diagnostic Imaging
  • Early Diagnosis
  • Electrocardiography
  • Humans
  • Microscopy, Electron
  • Myocardium
  • Prognosis
  • Journal Article
  • Review

Fingerprint

Dive into the research topics of 'Cardiac involvement with amyloidosis: mechanisms of disease, diagnosis and management'. Together they form a unique fingerprint.

Cite this